Baltimore, MD, United States of America

Jong Ho Chun


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Jong Ho Chun: Pioneering Pharmaceutical Formulations for Cancer Treatment

Introduction: Jong Ho Chun is an accomplished inventor based in Baltimore, MD, whose contributions to the field of pharmaceutical formulations have garnered attention in the fight against various neoplastic diseases. With two patents to his name, his innovations focus on enhancing cancer treatments through novel compositions.

Latest Patents: Jong Ho Chun's latest patents include groundbreaking formulations that leverage the therapeutic potential of NDGA derivatives. The first patent details the formulations of terameprocol and temozolomide, highlighting their application in stimulating humoral immunity against tumors. This invention is particularly relevant for treating conditions such as glioblastoma multiforme and lung cancers.

The second patent emphasizes compositions that combine NDGA derivatives with sorafenib, targeting a variety of cancers, including liver, colon, breast, brain, and ovarian cancers. This innovative combination aims to enhance the effectiveness of cancer treatments by utilizing additional therapeutic agents alongside NDGA derivatives.

Career Highlights: Throughout his career, Jong Ho Chun has made significant strides in pharmaceutical research. He has had the opportunity to work with prestigious institutions, including The Johns Hopkins University and Academia Sinica, where he has contributed to groundbreaking research and development in cancer therapies.

Collaborations: Collaboration has been a key aspect of Chun's career. He has worked alongside prominent colleagues such as David Mold and Ru Chih Huang. These collaborations have fostered the development of innovative treatments and underscore the importance of teamwork in the realm of scientific research.

Conclusion: Jong Ho Chun's contributions to pharmaceutical formulations represent a significant advancement in cancer treatment. Through his inventive patents and collaborations, he continues to be a vital figure in the ongoing battle against harmful neoplastic diseases. His work not only enhances treatment options for patients but also paves the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…